File Browser

NOVARTIS PHARMACEUTICALS CANADA INC. v. APOTEX INC. ET AL.

Summary of T-1484-16

The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.

Federal Court Type: S. 18.1 Patented Medicines (Notice of Compliance) Regulations

Parties and Lawyers:
PartyFirmLawyer
APOTEX INC
MINISTER OF HEALTH (THE)
NOVARTIS AG
NOVARTIS PHARMACEUTICALS CANADA INCGowling WLG (Canada) LLPCREBER, ANTHONY G
NOVARTIS PHARMACEUTICALS CANADA INC
Intellectual Property:
NameNumber
2255951

Patented Medicine: Deferasirox (Medicinal ingredients are based on automated analysis and should not be relied upon.)

Docket Summary (Google Translate to English)

() 2016-11-30 - Ottawa
Covering letter from Applicant dated 30-NOV-2016 concerning Doc. No. 16 placed on file on 30-NOV-2016
(16) 2016-11-30 - Ottawa
Discontinuance with Consent on behalf of Applicant filed on 30-NOV-2016
() 2016-10-24 - Ottawa
Acknowledgment of Receipt received from both parties with respect to the Order of the Court dated 21-Oct-2016 placed on file on 24-OCT-2016
(15) 2016-10-21 - Ottawa
Order dated 21-OCT-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The Respondent's evidence shall be served and proof of service thereof filed by December 12, 2016. 2. Motion records on any motion pursuant to Rule 312 shall be served and filed as soon as practicable but notice of such motion shall in any event be provided no later than December 19, 2016. 3. Cross-examinations on affidavits will be conducted no later than January 31, 2017. 4. The Applicant's record shall be served and file no later than February 27, 2017. 5. the Respondent's record shall be served and filed no later than March 24, 2017. 6. This application shall be heard in Ottawa, beginnign at 9:30 am on April 26, 2017 for a duration not exceeding two days Filed on 21-OCT-2016 copies sent to parties entered in J. & O. Book, volume 1316 page(s) 96 - 97 Interlocutory Decision
() 2016-10-20 - Ottawa
Ottawa 20-OCT-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: A scheduling order will issue as agreed upon by all parties held in chambers by way of Conference Call Duration per day: 20-OCT-2016 from 09:30 to 09:50 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 20min Appearances: Anthony Creber 613-786-0140 representing Applicant/Novartis Harry Radomski/Richard Naiberg 416-597-4142 representing Respondent/Apotex Comments: Hearing dates were discussed during the week of April 24th. Counsel have expressed a preference for the first week of May 2017. Minutes of Hearing entered in Vol. 960 page(s) 67 - 70 Abstract of Hearing placed on file
() 2016-10-19 - Ottawa
Letter from Apotex dated 19-OCT-2016 in response to Golwing WLG's letter of today's date on behalf of Novartis. We do not agree that the schedule we suggested in our letter dated October 16, 2016 is unworkable or unfair...(scanned to CMJ) received on 19-OCT-2016
() 2016-10-19 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 19-OCT-2016 directing that 'A case management telephone conference will be held on October 20, 2016 at 9:30a.m.' placed on file on 19-OCT-2016 Confirmed in writing to the party(ies)
() 2016-10-19 - Ottawa
Letter from Applicant (Novartis) dated 19-OCT-2016 in response to Apotex's letter dated October 17th, advising that their proposed schedule is unworkable and unfair for the reasons below... received on 19-OCT-2016
() 2016-10-17 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 17-OCT-2016 directing that 'Apotex's counsel is asked to provide its comments as to the schedule suggested in Counsel for Novartis' letter dated October 11, 2016 by the end of the day on October 19, 2016.' placed on file on 17-OCT-2016 Confirmed in writing to the party(ies)
() 2016-10-18 - Ottawa
Letter from Apotex dated 14-OCT-2016 in response to Novartis' letter dated October 11, 2016...Apotex proposes their own schedule (enclosed)-scanned to CMJ received on 18-OCT-2016
() 2016-10-11 - Ottawa
Letter from Applicant, Novartis Pharmaceuticals Canada Inc dated 11-OCT-2016 re: Proposed Schedule - to be placed before Tabib, P -scanned to CMT OTTAWA received on 11-OCT-2016
(14) 2016-10-11 - Ottawa
Solicitor's certificate of service on behalf of Adam Heckman confirming service of 1) Affidavit of Dr. James Wuest 2. Affidavit of Mr. Johann Peter 3. Affidavit of Mr. René Lattmann 4. Affidavit of Nancy Gallinger... upon the Respondents and the Respondent Patentee by email on 11-OCT-2016 filed on 11-OCT-2016
() 2016-10-05 - Ottawa
Acknowledgment of Receipt received from all parties by email with respect to Direction dated 4-OCT-2016 placed on file on 05-OCT-2016
() 2016-10-05 - Ottawa
Written directions received from the Court: Mireille Tabib, Prothonotary dated 04-OCT-2016 directing that The parties shall, no later than November 4, 2016, either jointly or separately, file written submissions as to the following matters and issues: (a) Whether any motion pursuant to Section 6(5)(a) or (b) of the PM (NOC) Regulations is contemplated, and if so, the timeframe for bringing such motion. (b) A proposed schedule for the further steps to be taken in this application, including whether the parties have agreed to a partial or full reversal of the order of filing evidence, and if not, whether any motion to that effect is contemplated, together with, as the case may be, a proposed schedule for filing the parties¿ respective motion materials on such a motion. (c) Both Counsel's joint availabilities to participate in a case management telephone conference to discuss the proposals, issues or matters listed above. placed on file on 05-OCT-2016 Confirmed in writing to the party(ies)
(13) 2016-10-05 - Ottawa
Consent on behalf of the Applicant and the Respondents to the electronic service of all documents in this action that are not required to be personally served. filed on 05-OCT-2016
() 2016-09-27 - Ottawa
Communication to the Court from the Registry dated 27-SEP-2016 re: New CM file-NOC
() 2016-09-19 - Ottawa
Acknowledgment of Receipt received from all parties by fax with respect to Order (Doc. no. 12) placed on file on 19-SEP-2016
(12) 2016-09-19 - Ottawa
Order dated 19-SEP-2016 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Motion ex proprio motu Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 19-SEP-2016 entered in J. & O. Book, volume 1313 page(s) 41 - 41 Final Decision
(11) 2016-09-19 - Toronto
Affidavit of service of Jessica Oliveira sworn on 19-SEP-2016 on behalf of Respondent (Apotex Inc.) confirming service of doc. 10 upon all parties by telecopier on 15-SEP-2016 filed on 19-SEP-2016
(10) 2016-09-15 - Toronto
Notice of appearance on behalf of Respondent (Apotex Inc.) filed on 15-SEP-2016
(9) 2016-09-14 - Ottawa
Affidavit of service of Josh Chernofsky sworn on 13-SEP-2016 on behalf of Applicant confirming service of doc 1 upon respondent for Apotex Inc. by personal service on 13-SEP-2016 filed on 14-SEP-2016
(8) 2016-09-14 - Ottawa
Affidavit of service of IAN XIE sworn on 13-SEP-2016 on behalf of Applicant confirming service of doc 1 upon the Minister of Health by personal service on 13-SEP-2016 filed on 14-SEP-2016
(7) 2016-09-13 - Ottawa
Affidavit of service of Nancy Gallinger sworn on 13-SEP-2016 on behalf of the Respondent Patentee, Novartis AG, confirming service of doc 6 - notice of appearance upon all parties by facsimile for the two respondents and in person for the Applicant on 13-SEP-2016 filed on 13-SEP-2016
(6) 2016-09-13 - Ottawa
Notice of appearance on behalf of Respondent Patentee, Novartis AG, filed on 13-SEP-2016
(5) 2016-09-13 - Ottawa
Affidavit of service of Nancy Gallinger sworn on 13-SEP-2016 on behalf of Applicant confirming service of doc 1 upon the Minister of Health and the Respondent/Patentee by personal service on 13-SEP-2016 filed on 13-SEP-2016
(4) 2016-09-12 - Toronto
Affidavit of service of James Adeney sworn on 12-SEP-2016 on behalf of Respondent (Minister of Health) confirming service of doc. 3 upon all parties by telecopier on 12-SEP-2016 with Exhibits A filed on 12-SEP-2016
(3) 2016-09-12 - Toronto
Notice of appearance on behalf of Respondent (Minister of Health) filed on 12-SEP-2016
(2) 2016-09-12 - Ottawa
Service copy of Doc. No. 1 with proof of service upon respondent for the Minister of Health on 12-SEP-2016 filed on 12-SEP-2016
(1) 2016-09-09 - Ottawa
Notice of application and 2 copies with regard to Judicial Review (s.18) returnable (but no hearing date indicated at this time) filed on 09-SEP-2016 Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes

The official version of the court proceeding information is available from the court websites directly:
Browse another proceeding. Enter Court File No:

Canadian Intellectual Property